EU Biosimilar Action: New Competitors For Remicade/Herceptin, Four More Products Await CHMP OK

 
• By Ian Schofield
Approved
The EU has approved more biosimilar versions of Remicade and Herceptin

More from Approvals

More from Product Reviews